ZINACEF - 0173-0352-10 - (cefuroxime)

Alphabetical Index


Drug Information of ZINACEF

Product NDC: 0173-0352
Proprietary Name: ZINACEF
Non Proprietary Name: cefuroxime
Active Ingredient(s): 750    mg/8.3mL & nbsp;   cefuroxime
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of ZINACEF

Product NDC: 0173-0352
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA050558
Marketing Category: NDA
Start Marketing Date: 20041124

Package Information of ZINACEF

Package NDC: 0173-0352-10
Package Description: 10 VIAL in 1 TRAY (0173-0352-10) > 8.3 mL in 1 VIAL

NDC Information of ZINACEF

NDC Code 0173-0352-10
Proprietary Name ZINACEF
Package Description 10 VIAL in 1 TRAY (0173-0352-10) > 8.3 mL in 1 VIAL
Product NDC 0173-0352
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name cefuroxime
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 20041124
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name CEFUROXIME SODIUM
Strength Number 750
Strength Unit mg/8.3mL
Pharmaceutical Classes Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]

Complete Information of ZINACEF


General Information